Mass spectrometric studies on the interaction of cisplatin and insulin

[1]  Jing Li,et al.  Enantioselectivity and catalysis improvements of Pseudomonas cepacia lipase with Tyr and Asp modification , 2015 .

[2]  A. House,et al.  Enzymatic and non-enzymatic mechanisms of dimesna metabolism , 2015, Amino Acids.

[3]  D. Russell,et al.  Size-to-charge dispersion of collision-induced dissociation product ions for enhancement of structural information and product ion identification. , 2014, Analytical chemistry.

[4]  Cheng Guo,et al.  Competitive formation of b2 and c2-H2O ions from b3 ions containing Asp residue during tandem mass spectrometry: the influence of neighboring Arg , 2014, Amino Acids.

[5]  Xianlin Han,et al.  Characterization and quantification of diacylglycerol species in biological extracts after one-step derivatization: a shotgun lipidomics approach. , 2014, Analytical chemistry.

[6]  John R Yates,et al.  Top down proteomics. , 2013, Analytical chemistry.

[7]  Andrea Sinz,et al.  Analysis of peptide secondary structures by photoactivatable amino acid analogues. , 2012, Angewandte Chemie.

[8]  Zhiqiang Liu,et al.  Studies of interaction between insulin and glutathione using electrospray ionization mass spectrometry. , 2012, Rapid communications in mass spectrometry : RCM.

[9]  Zhiqiang Liu,et al.  Probing the interaction of cisplatin with cytochrome C by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. , 2012, Analytical chemistry.

[10]  N. Kelleher,et al.  Nano-LC FTICR tandem mass spectrometry for top-down proteomics: routine baseline unit mass resolution of whole cell lysate proteins up to 72 kDa. , 2012, Analytical chemistry.

[11]  Maria Paola Costi,et al.  Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells , 2012, Amino Acids.

[12]  P. Sadler,et al.  Use of top-down and bottom-up Fourier transform ion cyclotron resonance mass spectrometry for mapping calmodulin sites modified by platinum anticancer drugs. , 2011, Analytical chemistry.

[13]  M. Gramiccia,et al.  A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition , 2011, Amino Acids.

[14]  J. Peter-Katalinic,et al.  Direct analysis of α- and β-chains of hemoglobins from mammalian blood samples by nanoESI mass spectrometry during in-capillary proteolytic digestion , 2011, Amino Acids.

[15]  G. Natile,et al.  Mechanistic insight into the inhibition of matrix metalloproteinases by platinum substrates. , 2009, Journal of medicinal chemistry.

[16]  P. Domingues,et al.  Mass spectrometry characterization of the glycation sites of bovine insulin by tandem mass spectrometry , 2009, Journal of the American Society for Mass Spectrometry.

[17]  F. L. King,et al.  Direct determination of the primary binding site of cisplatin on cytochrome c by mass spectrometry , 2009, Journal of the American Society for Mass Spectrometry.

[18]  M. Gómez-Gómez,et al.  Top-down mass spectrometric approach for the full characterization of insulin-cisplatin adducts. , 2009, Analytical chemistry.

[19]  A. Casini,et al.  Stability of an organometallic ruthenium-ubiquitin adduct in the presence of glutathione: relevance to antitumour activity. , 2008, Journal of inorganic biochemistry.

[20]  A. Casini,et al.  Peculiar mechanistic and structural features of the carboplatin–cytochrome c system revealed by ESI-MS analysis , 2008, JBIC Journal of Biological Inorganic Chemistry.

[21]  A. Sanz-Medel,et al.  Atomic (HPLC-ICP-MS) and molecular mass spectrometry (ESI-Q-TOF) to study cis-platin interactions with serum proteins , 2008 .

[22]  P. Dyson,et al.  Characterization of platinum anticancer drug protein-binding sites using a top-down mass spectrometric approach. , 2008, Inorganic chemistry.

[23]  Viktor Brabec,et al.  Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands. , 2007, Journal of medicinal chemistry.

[24]  L. Kèlland,et al.  The resurgence of platinum-based cancer chemotherapy , 2007, Nature Reviews Cancer.

[25]  Young Yang,et al.  The apoptotic effect of intercalating agents on HPV-negative cervical cancer C-33A cells , 2007, Amino Acids.

[26]  Stephen J Lippard,et al.  Direct cellular responses to platinum-induced DNA damage. , 2007, Chemical reviews.

[27]  P. Dyson,et al.  Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy , 2006 .

[28]  A. Casini,et al.  Structural investigation of cisplatin-protein interactions: selective platination of His19 in a cuprozinc superoxide dismutase. , 2006, Angewandte Chemie.

[29]  Dong Wang,et al.  Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.

[30]  Koichi Tanaka,et al.  The origin of macromolecule ionization by laser irradiation (Nobel lecture). , 2003, Angewandte Chemie.

[31]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[32]  M. Fuertes,et al.  Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. , 2003, Chemical reviews.

[33]  J. Reedijk.  Why does Cisplatin reach Guanine-n7 with competing s-donor ligands available in the cell? , 1999, Chemical reviews.

[34]  S. Lippard,et al.  Structure, Recognition, and Processing of Cisplatin-DNA Adducts. , 1999, Chemical reviews.

[35]  C. Costa Vera,et al.  Conformational stability of adsorbed insulin studied with mass spectrometry and hydrogen exchange. , 1999, Analytical chemistry.

[36]  J Christodoulou,et al.  Cisplatin Binding Sites on Human Albumin* , 1998, The Journal of Biological Chemistry.

[37]  Thomas G. Burke,et al.  DNA Interactions of Two Clinical Camptothecin Drugs Stabilize Their Active Lactone Forms , 1998 .

[38]  M. Wilm,et al.  Rapid Protein Sequencing by Tandem Mass Spectrometry and cDNA Cloning of p20-CGGBP , 1997, The Journal of Biological Chemistry.

[39]  H. Jaeschke,et al.  A possible role of plasma glutathione in glucose-mediated insulin secretion: in vitro and in vivo studies in rats , 1989, Diabetologia.

[40]  S. Lippard,et al.  Site-specifically platinated DNA, a new probe of the biological activity of platinum anticancer drugs , 1986 .

[41]  J R Yates,et al.  Protein sequencing by tandem mass spectrometry. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Sanger,et al.  The disulphide bonds of insulin. , 1955, The Biochemical journal.

[43]  Zijian Guo,et al.  The role of sulfur in platinum anticancer chemotherapy. , 2007, Anti-cancer agents in medicinal chemistry.

[44]  Seth M. Cohen,et al.  Cisplatin: from DNA damage to cancer chemotherapy. , 2001, Progress in nucleic acid research and molecular biology.